Literature DB >> 25572676

The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care.

Vasu Sunkara1, James R Hébert.   

Abstract

BACKGROUND: Disparities in cancer screening, incidence, treatment, and survival are worsening globally. The mortality-to-incidence ratio (MIR) has been used previously to evaluate such disparities.
METHODS: The MIR for colorectal cancer is calculated for all Organisation for Economic Cooperation and Development (OECD) countries using the 2012 GLOBOCAN incidence and mortality statistics. Health system rankings were obtained from the World Health Organization. Two linear regression models were fit with the MIR as the dependent variable and health system ranking as the independent variable; one included all countries and one model had the "divergents" removed.
RESULTS: The regression model for all countries explained 24% of the total variance in the MIR. Nine countries were found to have regression-calculated MIRs that differed from the actual MIR by >20%. Countries with lower-than-expected MIRs were found to have strong national health systems characterized by formal colorectal cancer screening programs. Conversely, countries with higher-than-expected MIRs lack screening programs. When these divergent points were removed from the data set, the recalculated regression model explained 60% of the total variance in the MIR.
CONCLUSIONS: The MIR proved useful for identifying disparities in cancer screening and treatment internationally. It has potential as an indicator of the long-term success of cancer surveillance programs and may be extended to other cancer types for these purposes.
© 2015 American Cancer Society.

Entities:  

Keywords:  clinical medicine; colorectal cancer; mass screening; public health

Mesh:

Year:  2015        PMID: 25572676      PMCID: PMC4424055          DOI: 10.1002/cncr.29228

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Income-related inequalities and inequities in health care services utilisation in 18 selected OECD countries.

Authors:  Marion Devaux
Journal:  Eur J Health Econ       Date:  2013-12-14

2.  [Colorectal cancer screening at Clínica Alemana, Santiago de Chile].

Authors:  Maria de los Angeles Silva; Ricardo Santander; Jaquelina Gobelet; Eduardo Valdivieso; Maria Antonieta Ramírez; Roque Sáenz; Gonzalo Alarcón; Soledad Elías; Lizzy Olivares
Journal:  Acta Gastroenterol Latinoam       Date:  2011-03

3.  Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients.

Authors:  Cathy J Bradley; Bassam Dahman; Harry D Bear
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

4.  Colorectal cancer in Portugal.

Authors:  Carlos Gouveia Pinto; Ana Teresa Paquete; Irene Pissarra
Journal:  Eur J Health Econ       Date:  2010-01

5.  Colon cancer treatment costs for Medicare and dually eligible beneficiaries.

Authors:  Zhehui Luo; Cathy J Bradley; Bassam A Dahman; Joseph C Gardiner
Journal:  Health Care Financ Rev       Date:  2010

6.  Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.

Authors:  Kathleen Lang; Lisa M Lines; David W Lee; Jonathan R Korn; Craig C Earle; Joseph Menzin
Journal:  Clin Gastroenterol Hepatol       Date:  2008-09-04       Impact factor: 11.382

Review 7.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.

Authors:  D Max Parkin; Freddie Bray
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

8.  The association between socio-demographic characteristics and adherence to breast and colorectal cancer screening: analysis of large sub populations.

Authors:  Rachel Wilf-Miron; Ronit Peled; Einat Yaari; Anna Vainer; Avi Porath; Ehud Kokia
Journal:  BMC Cancer       Date:  2011-08-25       Impact factor: 4.430

9.  Increasing trend of colorectal cancer incidence in Korea, 1999-2009.

Authors:  Aesun Shin; Kyee-Zu Kim; Kyu-Won Jung; Sohee Park; Young-Joo Won; Jeongseon Kim; Dae Yong Kim; Jae Hwan Oh
Journal:  Cancer Res Treat       Date:  2012-12-31       Impact factor: 4.679

10.  Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment?

Authors:  Emma Verastegui; Alejandro Mohar
Journal:  Eur J Health Econ       Date:  2010-01
View more
  42 in total

1.  Adams et al. Respond.

Authors:  Swann A Adams; Suel Ki Choi; Jan M Eberth; Heather M Brandt; Daniela B Friedman; James R Hébert
Journal:  Am J Public Health       Date:  2016-06       Impact factor: 9.308

2.  Epidemiological Trends in Colorectal Cancer in China: An Ecological Study.

Authors:  Jinzhou Zhu; Zhengqi Tan; Kelseanna Hollis-Hansen; Yong Zhang; Chaohui Yu; Youming Li
Journal:  Dig Dis Sci       Date:  2016-10-31       Impact factor: 3.199

3.  Trends in Gastrointestinal Cancer Mortality Rate in Hungary.

Authors:  Klaudia Farkas; Mónika Szűcs; Tibor András Nyári
Journal:  Pathol Oncol Res       Date:  2016-03-10       Impact factor: 3.201

4.  Potential for improvement in cancer management: reducing mortality in the European Union.

Authors:  Carlo La Vecchia; Matteo Rota; Matteo Malvezzi; Eva Negri
Journal:  Oncologist       Date:  2015-04-17

5.  Is Availability of Mammography Services at Federally Qualified Health Centers Associated with Breast Cancer Mortality-to-Incidence Ratios? An Ecological Analysis.

Authors:  Swann Arp Adams; Seul Ki Choi; Jan M Eberth; Daniela B Friedman; Mei Po Yip; Reginald D Tucker-Seeley; Lisa T Wigfall; James R Hébert
Journal:  J Womens Health (Larchmt)       Date:  2015-07-24       Impact factor: 2.681

6.  Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016.

Authors:  Rajesh Sharma
Journal:  Breast Cancer       Date:  2019-01-02       Impact factor: 4.239

7.  Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy.

Authors:  Paolo Giorgi Rossi; Massimo Vicentini; Claudio Sacchettini; Enza Di Felice; Stefania Caroli; Francesca Ferrari; Lucia Mangone; Annamaria Pezzarossi; Francesca Roncaglia; Cinzia Campari; Romano Sassatelli; Roberto Sacchero; Giuliana Sereni; Luisa Paterlini; Marco Zappa
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

8.  Insurance correlates with improved access to care and outcome among glioblastoma patients.

Authors:  Desmond A Brown; Benjamin T Himes; Panagiotis Kerezoudis; Yirengah M Chilinda-Salter; Sanjeet S Grewal; Joshua A Spear; Mohamad Bydon; Terry C Burns; Ian F Parney
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

9.  Trends in Mortality Rates for Gastrointestinal Cancers in Fars Province, Iran (2005-2015).

Authors:  Hossein-Ali Nikbakht; Sadaf Sahraian; Haleh Ghaem; Afshan Javadi; Maryam Janfada; Soheil Hassanipour; Ali-Reza Mirahmadizadeh
Journal:  J Gastrointest Cancer       Date:  2020-03

10.  Mortality-to-incidence ratios by US Congressional District: Implications for epidemiologic, dissemination and implementation research, and public health policy.

Authors:  Jan M Eberth; Whitney E Zahnd; Swann Arp Adams; Daniela B Friedman; Stephanie B Wheeler; James R Hébert
Journal:  Prev Med       Date:  2019-11-01       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.